{"id":131038,"date":"2026-06-25T13:16:34","date_gmt":"2026-06-25T07:46:34","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=131038"},"modified":"2026-06-25T13:16:36","modified_gmt":"2026-06-25T07:46:36","slug":"apollo-hospitals-latest-news-52-week-high-june-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/","title":{"rendered":"Apollo Hospitals Latest News: Apollo Hospitals Scales 52-Week High of Rs 8,626 Backed by Strong Fundamentals"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Apollo Hospitals latest news: NSE: APOLLOHOSP Rs 8,626 (latest). 52W high Rs 8,626. 52W low Rs 6,696.50. MCap Rs 1,23,272 Cr. P\/E 62.71x. 1Y gain from low: +~29%.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/stocks\/apollohosp\/apollo-hospitals-enterprise-ltd-share-price-today\">Apollo Hospitals<\/a> Latest News is in focus as <a href=\"https:\/\/univest.in\/stocks\/apollohosp\/apollo-hospitals-enterprise-ltd-share-price-today\">Apollo Hospitals Enterprise Ltd (NSE: APOLLOHOSP)<\/a> hit a 52-week high of Rs 8,626 today, extending a strong rally that has delivered ~29% returns from its 52-week low of Rs 6,696.50. The Healthcare and Hospitals company is backed by strong fundamentals and key business developments driving the Apollo Hospitals latest news rally.<\/p>\n<p>This Apollo Hospitals latest news analysis covers the key catalysts behind the 52-week high, what market analysts are observing, the next price targets and levels to watch, and the key risks investors should monitor.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=apollo-hospitals-latest-news-52-week-hig\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#About_Apollo_Hospitals_Company_Overview\" title=\"About Apollo Hospitals: Company Overview\">About Apollo Hospitals: Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#What_Is_Driving_the_Apollo_Hospitals_Latest_News_52-Week_High_Key_Reasons\" title=\"What Is Driving the Apollo Hospitals Latest News 52-Week High? Key Reasons\">What Is Driving the Apollo Hospitals Latest News 52-Week High? Key Reasons<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Q3_FY26_PAT_Jumped_3492_to_Rs_502_Crore_with_EBITDA_Up_2664\" title=\"Q3 FY26 PAT Jumped 34.92% to Rs 502 Crore with EBITDA Up 26.64%\">Q3 FY26 PAT Jumped 34.92% to Rs 502 Crore with EBITDA Up 26.64%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Composite_Scheme_of_Arrangement_Restructuring_for_Pharmacy_Margin_Visibility\" title=\"Composite Scheme of Arrangement: Restructuring for Pharmacy Margin Visibility\">Composite Scheme of Arrangement: Restructuring for Pharmacy Margin Visibility<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#ICRA_AAA_Stable_Rating_Confirms_Financial_Strength\" title=\"ICRA AAA Stable Rating Confirms Financial Strength\">ICRA AAA Stable Rating Confirms Financial Strength<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#What_Market_Analysts_Are_Saying_About_Apollo_Hospitals_Latest_News\" title=\"What Market Analysts Are Saying About Apollo Hospitals Latest News\">What Market Analysts Are Saying About Apollo Hospitals Latest News<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Apollo_Hospitals_Latest_News_Next_Share_Price_Targets_and_Key_Levels\" title=\"Apollo Hospitals Latest News: Next Share Price Targets and Key Levels\">Apollo Hospitals Latest News: Next Share Price Targets and Key Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Key_Risks_to_Monitor\" title=\"Key Risks to Monitor\">Key Risks to Monitor<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Apollo_247_Digital_Health_Costs_Weighing_on_EBITDA_Margin\" title=\"Apollo 24\/7 Digital Health Costs Weighing on EBITDA Margin\">Apollo 24\/7 Digital Health Costs Weighing on EBITDA Margin<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Valuation_at_6271x_PE_Requires_Sustained_PAT_Growth\" title=\"Valuation at 62.71x P\/E Requires Sustained PAT Growth\">Valuation at 62.71x P\/E Requires Sustained PAT Growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#NCLT_Scheme_Execution_Risk\" title=\"NCLT Scheme Execution Risk\">NCLT Scheme Execution Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Frequently_Asked_Questions_on_Apollo_Hospitals_Latest_News\" title=\"Frequently Asked Questions on Apollo Hospitals Latest News\">Frequently Asked Questions on Apollo Hospitals Latest News<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#What_is_Apollo_Hospitals_latest_news_today\" title=\"What is Apollo Hospitals latest news today?\">What is Apollo Hospitals latest news today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Why_is_Apollo_Hospitals_at_52-week_high\" title=\"Why is Apollo Hospitals at 52-week high?\">Why is Apollo Hospitals at 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#What_is_Apollo_Hospitals_composite_scheme_of_arrangement\" title=\"What is Apollo Hospitals&#8217; composite scheme of arrangement?\">What is Apollo Hospitals&#8217; composite scheme of arrangement?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#What_is_Apollo_Hospitals_Q3_FY26_performance\" title=\"What is Apollo Hospitals&#8217; Q3 FY26 performance?\">What is Apollo Hospitals&#8217; Q3 FY26 performance?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#What_is_Apollo_Hospitalss_market_cap_and_valuation_at_the_52-week_high\" title=\"What is Apollo Hospitals&#8217;s market cap and valuation at the 52-week high?\">What is Apollo Hospitals&#8217;s market cap and valuation at the 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/apollo-hospitals-latest-news-52-week-high-june-2026\/#Is_Apollo_Hospitals_a_buy_at_the_52-week_high\" title=\"Is Apollo Hospitals a buy at the 52-week high?\">Is Apollo Hospitals a buy at the 52-week high?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Apollo_Hospitals_Company_Overview\"><\/span><strong>About Apollo Hospitals: Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>India&#8217;s largest private hospital network with 10,200 beds across 73 hospitals globally. Apollo Hospitals operates in healthcare services (hospitals, day surgery, cradles), digital health (Apollo 24\/7), pharmacy (integrated with Keimed Health), diagnostics, and health insurance. The company is pursuing a composite scheme of arrangement (NCLT approval in progress) to restructure its omni-channel pharmacy and digital health businesses for improved margin visibility.<\/p>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; margin: 12px 0;\">\n<tbody>\n<tr style=\"background: #1F3864; color: #ffffff;\">\n<th style=\"padding: 8px; text-align: left;\">Metric<\/th>\n<th style=\"padding: 8px; text-align: left;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">CMP (Latest)<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Rs 8,626<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">52-Week High<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Rs 8,626<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">52-Week Low<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Rs 6,696.50<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Market Cap<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Rs 1,23,272 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">P\/E Ratio (TTM)<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">62.71x<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Sector<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Healthcare and Hospitals<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">1-Year Return from Low<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">+~29%<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">NSE Symbol<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">NSE: APOLLOHOSP<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_Driving_the_Apollo_Hospitals_Latest_News_52-Week_High_Key_Reasons\"><\/span><strong>What Is Driving the Apollo Hospitals Latest News 52-Week High? Key Reasons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Three key developments have powered the Apollo Hospitals latest news stock to a fresh 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Q3_FY26_PAT_Jumped_3492_to_Rs_502_Crore_with_EBITDA_Up_2664\"><\/span><strong>Q3 FY26 PAT Jumped 34.92% to Rs 502 Crore with EBITDA Up 26.64%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Apollo Hospitals posted Q3 FY26 net profit of Rs 502.30 crore, a 34.92% year-on-year increase, with EBITDA growing 26.64% to Rs 965 crore. The strong performance reflects improved hospital occupancy, higher Average Revenue Per Occupied Bed (ARPOB), and the scaling of Apollo 24\/7 digital health platform. PBT grew 27.19% year-on-year to Rs 682 crore, reflecting operational leverage across the hospital network.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Composite_Scheme_of_Arrangement_Restructuring_for_Pharmacy_Margin_Visibility\"><\/span><strong>Composite Scheme of Arrangement: Restructuring for Pharmacy Margin Visibility<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Apollo Hospitals is pursuing a composite scheme of arrangement through NCLT, with a secured creditors meeting held on June 24, 2026 to approve the scheme. The restructuring aims to separate and optimise the omni-channel pharmacy and digital health business (Apollo 24\/7), which is nearing break-even. The scheme is expected to improve the clarity and visibility of pharmacy margins, unlock value from the digital health platform, and simplify the corporate structure for investors.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"ICRA_AAA_Stable_Rating_Confirms_Financial_Strength\"><\/span><strong>ICRA AAA Stable Rating Confirms Financial Strength<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Apollo Hospitals Enterprise received affirmation in its ICRA AAA\/Stable credit rating for bank facilities and ICRA A1+ for short-term bank facilities. The AAA rating, the highest possible from ICRA, reflects Apollo&#8217;s exceptional financial position, strong hospital operations, brand equity, and the ability to raise debt at competitive rates to fund network expansion. The credit rating affirmation directly precedes the 52-week high.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Use the Univest Screener to Track Live Price and Key Fundamentals<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Market_Analysts_Are_Saying_About_Apollo_Hospitals_Latest_News\"><\/span><strong>What Market Analysts Are Saying About Apollo Hospitals Latest News<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Apollo Hospitals Enterprise is one of the highest-conviction Indian healthcare names in institutional portfolios, backed by ICRA AAA credit rating, market leadership in private hospital services, and the Apollo 24\/7 digital health platform approaching profitability. The five-year net income CAGR of 26.02% reflects consistent compounding in a structurally growing sector. The NCLT scheme approval is the key near-term catalyst that could simplify the stock&#8217;s valuation and attract fresh institutional buying.<\/p>\n<p>Ankit Jaiswal, Senior Research Analyst at Univest, notes that the Apollo Hospitals latest news 52-week high is supported by genuine fundamental strength and the stock&#8217;s technical structure is bullish across all major moving average timeframes. He cautions that new positions at the 52-week high carry short-term correction risk and recommends waiting for consolidation above Rs 8,000 before initiating fresh positions.<\/p>\n<p>Kunal Singla, Research Analyst at Univest, observes that as long as the Apollo Hospitals latest news stock holds above Rs 8,000 on weekly closes, the bullish trend structure remains intact and the Rs 9,000 to 9,500 zone is achievable over the coming weeks. He notes that the stock&#8217;s 52-week high breakout is technically significant and signals continued institutional accumulation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Apollo_Hospitals_Latest_News_Next_Share_Price_Targets_and_Key_Levels\"><\/span><strong>Apollo Hospitals Latest News: Next Share Price Targets and Key Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Following the 52-week high, the key price levels for the Apollo Hospitals latest news story are:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; font-size: 14px; margin: 12px 0;\">\n<tbody>\n<tr style=\"background: #1F3864; color: #ffffff;\">\n<th style=\"padding: 8px; text-align: left;\">Level<\/th>\n<th style=\"padding: 8px; text-align: left;\">Price (Rs)<\/th>\n<th style=\"padding: 8px; text-align: left;\">Significance<\/th>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">52-Week High (Current)<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">8,626<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">New breakout level today<\/td>\n<\/tr>\n<tr style=\"background: #F5F7FA;\">\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Near-Term Target<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">9,000 to 9,500<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Based on analyst views and technical momentum<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Key Support<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">8,000<\/td>\n<td style=\"padding: 8px; border-bottom: 1px solid #ddd;\">Weekly close support; hold here = trend intact<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>These levels are technical reference points and not guaranteed investment targets. Please consult a SEBI-registered financial advisor before making any investment decision in Apollo Hospitals.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Monitor\"><\/span><strong>Key Risks to Monitor<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Apollo_247_Digital_Health_Costs_Weighing_on_EBITDA_Margin\"><\/span><strong>Apollo 24\/7 Digital Health Costs Weighing on EBITDA Margin<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Apollo 24\/7 digital health costs of Rs 124 crore per quarter are included in the reported EBITDA, reducing the hospital network&#8217;s standalone margin visibility. The digital platform is nearing break-even but has not yet reached profitability. Until the restructuring under the composite scheme isolates these costs, the reported EBITDA margin will appear compressed relative to pure-play hospital operator peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_at_6271x_PE_Requires_Sustained_PAT_Growth\"><\/span><strong>Valuation at 62.71x P\/E Requires Sustained PAT Growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At 62.71x P\/E, Apollo Hospitals&#8217; stock price prices in continued strong PAT growth of 25 to 30% per year. Any quarter of flat or declining profit due to cost inflation, competitive entry by new hospitals, or slower ARPOB growth would be met with a sharp valuation correction from the current 52-week high levels.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"NCLT_Scheme_Execution_Risk\"><\/span><strong>NCLT Scheme Execution Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The composite scheme of arrangement being pursued by Apollo through NCLT involves regulatory approvals, shareholder votes, and creditor consents. Any delay in receiving approvals, legal challenges from creditors, or changes in the scheme structure could postpone the expected margin clarity benefit and weigh on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Apollo Hospitals latest news 52-week high today is backed by strong fundamental performance and significant business catalysts. Ankit Jaiswal of Univest notes the fundamental story is compelling and the technical structure remains bullish. Kunal Singla observes that as long as the stock holds Rs 8,000 on weekly closes, the target zone of Rs 9,000 to 9,500 remains achievable. Investors should track the <a href=\"https:\/\/univest.in\/indices\/nifty-pharma\/nifty-pharma-share-price-today\">Nifty Pharma<\/a> index for sector-level signals alongside company-specific developments. Please consult a SEBI-registered investment advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Apollo Hospitals live price and receive expert daily stock research.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Apollo_Hospitals_Latest_News\"><\/span><strong>Frequently Asked Questions on Apollo Hospitals Latest News<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Apollo_Hospitals_latest_news_today\"><\/span><strong>What is Apollo Hospitals latest news today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apollo Hospitals latest news is that the stock hit a 52-week high of Rs 8,626, driven by strong Q3 FY26 PAT growth of 34.92% to Rs 502 crore, EBITDA growth of 26.64% to Rs 965 crore, ICRA AAA\/Stable credit rating affirmation, and the NCLT composite scheme creditors meeting held on June 24, 2026 to restructure the pharmacy and digital health businesses.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Apollo_Hospitals_at_52-week_high\"><\/span><strong>Why is Apollo Hospitals at 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apollo Hospitals is at a 52-week high because of Q3 FY26 PAT rising 34.92% to Rs 502 crore, EBITDA growth of 26.64%, ICRA AAA Stable rating affirmation, and the composite scheme of arrangement progressing through NCLT that is expected to improve pharmacy and digital health margin visibility.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Apollo_Hospitals_composite_scheme_of_arrangement\"><\/span><strong>What is Apollo Hospitals&#8217; composite scheme of arrangement?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apollo Hospitals is pursuing an NCLT-approved composite scheme of arrangement to restructure its omni-channel pharmacy and digital health (Apollo 24\/7) businesses. A secured creditors meeting was held on June 24, 2026 to approve the scheme. The restructuring aims to separate and optimise the pharmacy business (integrated with Keimed Health) and the Apollo 24\/7 digital health platform, both of which are nearing break-even, to improve margin visibility for investors.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Apollo_Hospitals_Q3_FY26_performance\"><\/span><strong>What is Apollo Hospitals&#8217; Q3 FY26 performance?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apollo Hospitals Q3 FY26 net profit jumped 34.92% to Rs 502.30 crore, PBT grew 27.19% to Rs 682 crore, and EBITDA grew 26.64% to Rs 965 crore. This includes Apollo 24\/7 digital health costs of Rs 124 crore. The board declared an Rs 10 per share interim dividend for the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Apollo_Hospitalss_market_cap_and_valuation_at_the_52-week_high\"><\/span><strong>What is Apollo Hospitals&#8217;s market cap and valuation at the 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At the 52-week high of Rs 8,626, Apollo Hospitals has a market capitalisation of approximately Rs 1,23,272 crore and trades at a P\/E ratio of 62.71x. The 52-week low is Rs 6,696.50. All data should be verified at nseindia.com or bseindia.com before making any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Apollo_Hospitals_a_buy_at_the_52-week_high\"><\/span><strong>Is Apollo Hospitals a buy at the 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apollo Hospitals is at a 52-week high, which means the stock is in price discovery territory without historical supply overhang. While this is technically a bullish signal, buying at 52-week highs carries short-term correction risk. Ankit Jaiswal of Univest recommends waiting for consolidation above Rs 8,000 before considering a fresh position. This is not investment advice. Consult a SEBI-registered financial advisor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Latest Apollo Hospitals latest news: Apollo Hospitals hits 52-week high of Rs 8,626. Analyst views, next targets and key risks for investors.<\/p>\n","protected":false},"author":28,"featured_media":131126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-131038","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1782373600:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["74"],"rank_math_title":["Apollo Hospitals Latest News: Apollo Hospitals Hits 52-Week High"],"rank_math_description":["Apollo Hospitals latest news: Apollo Hospitals (NSE: APOLLOHOSP) hits 52-week high Rs 8,626. MCap Rs 1,23,272 Cr, P\/E 62.71x. Analyst views and next targets."],"rank_math_focus_keyword":["Apollo Hospitals Latest News"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["131126"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["21244"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Apollo-Hospitals-Latest-News.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131038","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=131038"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131038\/revisions"}],"predecessor-version":[{"id":131127,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/131038\/revisions\/131127"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/131126"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=131038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=131038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=131038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}